Replies to post #102747 on Biotech Values

[masterlongevity]

Genentech had a good inkling that the TDM-1 BLA would be refused. they were taking a calculated gamble. this was not a complete surprise

[cooldrinkh2o]

Agree.........I find it interesting that Roche has yet to make public the durability of response for all the responders in that trial. If the responses were durable, then I think the FDA would be hard pressed to RTF (unless there was a high percentage of missing scans or some other data management issues).